103 related articles for article (PubMed ID: 4366936)
1. Alveolar cell carcinoma-like antigen and antibodies in patients with alveolar cell carcinoma and other cancers.
Mohr AJ; Nordquist RE; Rhoades ER; Coalson RE; Coalson JJ
Cancer Res; 1974 Aug; 34(8):1904-7. PubMed ID: 4366936
[No Abstract] [Full Text] [Related]
2. Lymphocyte-associated antigens in patients with alveolar cell carcinoma.
Mohr JA; Nordquist RE; Coalson RE; Rhoades ER; Coalson JJ
J Lab Clin Med; 1975 Sep; 86(3):490-3. PubMed ID: 168280
[TBL] [Abstract][Full Text] [Related]
3. Specific antigens in human alveolar cell carcinoma.
Nordquist RE
Cancer Res; 1973 Jul; 33(7):1790-5. PubMed ID: 4352799
[No Abstract] [Full Text] [Related]
4. Seroepidemiology of human sarcoma antigen (S1).
Hirshaut Y; Pei DT; Marcove RC; Mukherji B; Spielvogel AR; Essner E
N Engl J Med; 1974 Nov; 291(21):1103-7. PubMed ID: 4608025
[No Abstract] [Full Text] [Related]
5. Characterization of a tumor cell surface protein with heterologous antisera to a spontaneous BALB/c lung carcinoma.
Kennel SJ
Cancer Res; 1979 Aug; 39(8):2934-9. PubMed ID: 222438
[TBL] [Abstract][Full Text] [Related]
6. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
7. Antigenic heterogeneity of human lung cancers.
Harłozińska A; Richter R; Albert Z; Zawadzka H
J Natl Cancer Inst; 1983 Mar; 70(3):427-33. PubMed ID: 6300497
[TBL] [Abstract][Full Text] [Related]
8. Characterization of two human small cell lung carcinoma-reactive monoclonal antibodies generated by a novel immunization approach.
Tong AW; Lee J; Stone MJ
Cancer Res; 1984 Nov; 44(11):4987-92. PubMed ID: 6207911
[TBL] [Abstract][Full Text] [Related]
9. A direct relationship between immune competence and the subcutaneous growth rate of a malignant murine lung tumor.
Yuhas JM; Pazmino NH; Proctor JO; Toya RE
Cancer Res; 1974 Apr; 34(4):722-8. PubMed ID: 4360837
[No Abstract] [Full Text] [Related]
10. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
Shitara K; Hanai N; Yoshida H
Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
[TBL] [Abstract][Full Text] [Related]
11. Isolation of lung carcinoma-associated antibodies from immune complexes and production of heterologous antisera.
Cronin WJ; Dorsett BH; Ioachim HL
Cancer Res; 1982 Jan; 42(1):292-300. PubMed ID: 7032694
[TBL] [Abstract][Full Text] [Related]
12. [Availability of the carbohydrate antigen (sialylated Lewis) as a tumor marker in pleural effusion].
Hiratani K; Hirota M; Fukushima K; Tomonaga A; Saito A; Hara K; Fujiwara K
Gan To Kagaku Ryoho; 1986 Aug; 13(8):2678-80. PubMed ID: 3017233
[No Abstract] [Full Text] [Related]
13. Present trends in lung cancer.
Ioachim HL
Monogr Pathol; 1978; 19():192-214. PubMed ID: 218097
[No Abstract] [Full Text] [Related]
14. Monoclonal antibodies to surface antigens of small cell carcinoma of the lung.
Okabe T; Kaizu T; Fujisawa M; Watanabe J; Kojima K; Yamashita T; Takaku F
Cancer Res; 1984 Nov; 44(11):5273-8. PubMed ID: 6091874
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
[TBL] [Abstract][Full Text] [Related]
16. An assessment of MAC 387 antibody as a diagnostically useful marker of L1 epithelial antigen expression by lung tumours.
Fitzmaurice RJ; Butterworth DM; Benbow EW
J Pathol; 1991 Nov; 165(3):269. PubMed ID: 1762034
[No Abstract] [Full Text] [Related]
17. Pulmonary carcinoma (Jaagsiekte) of sheep. Ultrastructural study of early and advanced tumor lesions.
Hod I; Herz A; Zimber A
Am J Pathol; 1977 Mar; 86(3):545-58. PubMed ID: 190891
[TBL] [Abstract][Full Text] [Related]
18. Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies.
Varki NM; Reisfeld RA; Walker LE
Cancer Res; 1984 Feb; 44(2):681-7. PubMed ID: 6362852
[TBL] [Abstract][Full Text] [Related]
19. Immunological reactivity of glycoprotein antigens from human lung cancers.
Harłozińska A; Lisowska E; Richter R; Albert W; Gawlikowski W; Domagała J
Neoplasma; 1980; 27(6):641-52. PubMed ID: 7254422
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the antigen identified by Po66. A monoclonal antibody raised against a lung squamous cell carcinoma.
Martin A; Pellen P; Guitton C; Youinou P; Collet B; Desrues B; Bourel D; Dazord L; Toujas L
Cancer Immunol Immunother; 1989; 29(2):118-24. PubMed ID: 2541906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
